Ken Griffin Intercure Ltd. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Intercure Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 8,100 shares of INCR stock, worth $12,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,100
Previous 2,900
179.31%
Holding current value
$12,798
Previous $5,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INCR
# of Institutions
22Shares Held
3.32MCall Options Held
8.1KPut Options Held
500-
Ibex Investors LLC1.89MShares$2.98 Million5.03% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$1.28 Million0.06% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$335,7500.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD108KShares$170,7090.03% of portfolio
-
Moore Capital Management, LP New York, NY97.3KShares$153,6910.0% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $71.3M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...